United States · Biotechnology startup

Apogee Therapeutics

Apogee Therapeutics is a biotechnology company that offers therapies for immunological and inflammatory disorders.

Funding reportedLast round: Post-IPO Debt

BiotechnologySan Francisco, United States

What company datasets say Apogee Therapeutics raised

Funding, as reported

Reported in all$1.3Bin dollars
Last roundPost-IPO Debt
Investors listed5

Founders and team

From Apogee Therapeutics's own website: 4 on the team.

  • Dan MulreanyChief Business Officer
  • Jane Pritchett HendersonChief Financial Officer
  • Jeff HartnessChief Commercial Officer
  • Emily CoxSVP, Head of People

On a portfolio page

Investors who name them

Each firm lists Apogee Therapeutics on its own website. That is the firm's claim, a weaker thing than a round we watched, but a named source.

Biotechnology in United States

Startups like it

Is this your company?

Add your raise, your deck and your story, and put Apogee Therapeutics in front of investors. Or tell us what we have wrong.

List your startupSend a correction